Edecrina en es it fr

Edecrina Brand names, Edecrina Analogs

Edecrina Brand Names Mixture

  • No information avaliable

Edecrina Chemical_Formula


Edecrina RX_link


Edecrina fda sheet

Edecrina FDA

Edecrina msds (material safety sheet)

Edecrina MSDS

Edecrina Synthesis Reference

No information avaliable

Edecrina Molecular Weight

303.137 g/mol

Edecrina Melting Point

122.5 oC

Edecrina H2O Solubility

No information avaliable

Edecrina State


Edecrina LogP


Edecrina Dosage Forms

Tablet (25, 50 mg); Powder for solution

Edecrina Indication

For the treatment of high blood pressure and edema caused by diseases like congestive heart failure, liver failure, and kidney failure.

Edecrina Pharmacology

Ethacrynic acid is a monosulfonamyl loop or high ceiling diuretic. Ethacrynic acid acts on the ascending limb of the loop of Henle and on the proximal and distal tubules. Urinary output is usually dose dependent and related to the magnitude of fluid accumulation. Water and electrolyte excretion may be increased several times over that observed with thiazide diuretics, since ethacrynic acid inhibits reabsorption of a much greater proportion of filtered sodium than most other diuretic agents. Therefore, ethacrynic acid is effective in many patients who have significant degrees of renal insufficiency. Ethacrynic acid has little or no effect on glomerular filtration or on renal blood flow, except following pronounced reductions in plasma volume when associated with rapid diuresis.

Edecrina Absorption

Onset of action is rapid, usually within 30 minutes after an oral dose of ethacrynic acid or within 5 minutes after an intravenous injection of ethacrynic acid.

Edecrina side effects and Toxicity

Overdosage may lead to excessive diuresis with electrolyte depletion.

Edecrina Patient Information

No information avaliable

Edecrina Organisms Affected

Humans and other mammals